Form 4: Teva Pharmaceutical Industries Officer Reports Share Transactions
SEC Form 4
Vikki L. Conway, an officer at Teva Pharmaceutical Industries, reported the acquisition and disposal of ordinary shares and restricted share units.
Summary
- On March 3, 2024, Vikki L. Conway acquired 5,179 ordinary shares through vesting of restricted share units.
- On March 4, 2024, Conway sold 1,490 ordinary shares at a weighted average price of $13.3733 to cover tax obligations related to vesting restricted share units.
- Also on March 4, 2024, Conway acquired 7,117 ordinary shares through vesting of restricted share units.
- Conway then sold 2,042 ordinary shares at a weighted average price of $13.3733 to cover tax obligations related to vesting restricted share units.
- Conway also acquired 33,482 restricted share units on March 4, 2024, which vest in installments from March 4, 2025, to March 4, 2028.
- These transactions were made pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company officers.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the amounts are relatively small.
Key Dates
| Date | Description |
|---|---|
| 2023-03-03 | Restricted share units were granted, with 5,179 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 5,180 vesting on March 3, 2027. |
| 2023-11-21 | Reporting person adopted a Rule 10b5-1 trading plan. |
| 2024-03-03 | Vikki L. Conway acquired 5,179 ordinary shares through vesting of restricted share units. |
| 2024-03-04 | Vikki L. Conway sold 1,490 ordinary shares at a weighted average price of $13.3733 to cover tax obligations related to vesting restricted share units. |
| 2024-03-04 | Vikki L. Conway acquired 7,117 ordinary shares through vesting of restricted share units. |
| 2024-03-04 | Vikki L. Conway sold 2,042 ordinary shares at a weighted average price of $13.3733 to cover tax obligations related to vesting restricted share units. |
| 2024-03-04 | Vikki L. Conway acquired 33,482 restricted share units which vest in installments from March 4, 2025, to March 4, 2028. |
| 2025-03-03 | 5,179 restricted share units vest. |
| 2025-03-04 | 8,370 restricted share units vest. |
| 2026-03-03 | 5,179 restricted share units vest. |
| 2026-03-04 | 8,370 restricted share units vest. |
| 2027-03-03 | 5,180 restricted share units vest. |
| 2027-03-04 | 8,370 restricted share units vest. |
| 2028-03-04 | 8,372 restricted share units vest. |
| 2024-03-05 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.